ArticleLangenbeck's archives of surgery2025
Predictive factors for the detection of occult metastases during staging laparoscopy in patients with gastric carcinoma and adenocarcinoma of the esophagogastric junction.
Article in Langenbeck's archives of surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPeritoneal metastasis can occur in all stages of gastric cancer (GC) and adenocarcinoma of the esophagogastric junction (AEG) but staging laparoscopy (SL) is recommended for advanced stages. This study aimed to evaluate predictive factors for the detection of further, previously unknown (occult) metastases during SL. MATERIALS &
methodsWe conducted a retrospective analysis of patients who underwent SL at our center between 2005 and 2018. Binary logistic regression analysis was used to identify risk factors for the occurrence of occult metastasis.
resultsA total of 232 patients were included in the analysis. Occult metastases were detected in 48 (20.7%) patients. Forty patients (17.2%) had peritoneal carcinomatosis, 4 (1.6%) had liver metastases, 3 (1.2%) had peritoneal and liver metastases, and 1 (0.4%) had omental metastases. Univariate analysis revealed that cT4 category; cM-positivity; WHO G3 grade; histology results revealing diffuse, mixed or undifferentiated Lauren subtypes; and signet ring cells were significant risk factors for occult metastasis. Multivariate analysis confirmed that cM-positive stage (OR: 17.672; 95% CI: 3.06 to 102.052; p = 0.001) and signet ring cell count (OR: 6.228; 95% CI: 1.151 to 33.716; p = 0.034) were independently associated with occult metastasis detection by SL.
conclusionOccult metastases are common in patients with GC or AEG who undergo SL. Histological evidence of signet ring cells should be considered a high-risk histology result and should be an independent indication for SL. Patients with positive cM staging might benefit from SL because of the high probability of further occult metastases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.